This latest news was revealed during Oracle’s recent Q2 2025 earnings call, where Larry Ellison, Chairman and Chief ...

Data was gathered from key stakeholders, including Fordham students, along the five major Commercial Corridors in Fordham Manor - Fordham Road, Jerome Avenue, Grand Concourse, Webster Avenue, and ...

Detailed price information for CI Bio Revolution ETF (CDNA-T) from The Globe and Mail including charting and trades.

In a report released yesterday, Mark Massaro from BTIG reiterated a Buy rating on CareDx (CDNA – Research Report), with a price target of ...

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox ...

Detailed price information for CI Bio Revolution ETF (CDNA-T) from The Globe and Mail including charting and trades.

CareDx continues its growth trajectory with solid margins and EBITDA. Find out why CDNA stock offers a promising outlook ...

The stock market is in the midst of a sell-off right now, with the Nasdaq Composite down more than 9% from its recent ...

CareDx (CDNA) announced that AlloSure is now commercially available for pediatric heart transplant patients of all ages and patients who have ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Stock analysts at HC Wainwright decreased their Q1 2025 earnings per share estimates for shares of CareDx in a research note issued on Monday, March 3rd. HC Wainwright analyst Y. Chen now forecasts ...